Providers utilize business intelligence to monitor referral patterns and collaborate with clinicians who order their services. Such analytics tools have also been deployed in the specialty to improve productivity, track patient satisfaction and bolster quality.
Paxton says the “woke” EHR giant is intentionally making it harder for patients and families to access historical medical data, violating state law. Epic denies the allegation.
Mark Cuban's startup Cost Plus Drugs and insurer Humana are said to be working on a deal that would allow Medicare Advantage patients to buy drugs directly from manufacturers. The terms of the agreement—which Forbes reports is in its early stages—are still unknown.
The results were shown in multiple posts on X. A clinical trial to prove the safety and efficacy of Elon Musk's brain implant is ongoing, with 12 people currently using the devices.
The all-cash deal is expected to be finalized in April 2026. With this divestment of its ambulatory labs, Tennessee-based Community Health Systems said it will be better able to focus on its core patient care business.
The FDA has OK’d an algorithm that automatically ratios the diameter of the right ventricle vs. that of the left on CT pulmonary angiography studies for patients with pulmonary embolism (PE).
The Swedish imaging IT and cybersecurity company best known as a highly rated PACS supplier has retooled its enterprise imaging platform to incorporate genomics data.
Last week CMS dug in with its decision to put off finalizing an alternative value-based payment model for radiation oncology services to “a date to be determined through future rulemaking.”
"We are filing these lawsuits to protect the innovative mRNA technology platform that we pioneered, invested billions of dollars in creating, and patented during the decade preceding the COVID-19 pandemic," says Moderna CEO Stéphane Bancel.
Children’s Hospital New Orleans is tapping Cleveland Clinic as a way to make sure Pelican State families have ready access to board-certified pediatric radiologists.
United Imaging Healthcare of Shanghai just became the seventh Chinese company this year to enjoy an IPO topping $1 billion—and the third best-performing of the bunch.